I don’t know; was mainly jerking mcbio’s chain, although I do think the rejected application might be Simeprevir. The FDA has granted so many BT designations for HCV, JNJ may have figured there was nothing to lose by trying.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”